MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences DIO Ratio 2011-2026 | ANIX
Quarterly DIO Ratio Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.54 | 1.39 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.39 | 0.54 | 0.965 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
177 | $ 8.92 | 0.56 % | $ 594 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 26.01 | 0.68 % | $ 722 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
115 | $ 68.2 | 2.8 % | $ 26.6 B | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 154.35 | 1.57 % | $ 7.65 B | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 17.52 | 1.18 % | $ 934 M | USA |
 |
Guardant Health
GH
|
82.1 | $ 87.53 | 0.4 % | $ 11 B | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | $ 103.87 | 0.01 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 15.53 | 3.88 % | $ 470 M | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 99.43 | 1.86 % | $ 8.2 B |  Irlanda |
 |
Danaher Corporation
DHR
|
87.6 | $ 194.97 | 1.87 % | $ 139 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
137 | $ 121.42 | 1.79 % | $ 19.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 199.2 | 0.13 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
97.1 | $ 113.43 | 1.43 % | $ 34.5 B | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.12 | 0.66 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 9.28 | 10.24 % | $ 263 M |  Israel |
 |
NeoGenomics
NEO
|
24.4 | $ 8.36 | 1.46 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.24 | 1.43 % | $ 2 B | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 78.46 | -0.05 % | $ 5.3 B | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Pacific Biosciences of California
PACB
|
173 | $ 1.41 | 3.31 % | $ 423 M | USA |
 |
Co-Diagnostics
CODX
|
304 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 215.3 | 1.35 % | $ 25 B |  Schweiz |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
25.8 | $ 199.43 | 0.89 % | $ 19.6 B | USA |
 |
OPKO Health
OPK
|
45.2 | $ 1.2 | 0.42 % | $ 833 M | USA |